Literature DB >> 19874152

Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.

Shannon Gwin Mitchell1, Sharon M Kelly, Barry S Brown, Heather Schacht Reisinger, James A Peterson, Adrienne Ruhf, Michael H Agar, Kevin E O'Grady, Robert P Schwartz.   

Abstract

This study examined the uses of diverted methadone and buprenorphine among opiate-addicted individuals recruited from new admissions to methadone programs and from out-of-treatment individuals recruited from the streets. Self-report data regarding diversion were obtained from surveys and semi-structured qualitative interviews. Approximately 16% (n = 84) of the total sample (N = 515) reported using diverted (street) methadone two-three times per week for six months or more, and for an average of 7.8 days (SD = 10.3) within the past month. The group reporting lifetime use of diverted methadone as compared to the group that did not report such use was less likely to use heroin and cocaine in the 30 days prior to admission (ps <.01) and had lower ASI Drug Composite scores (p <.05). Participants in our qualitative sub-sample (n = 22) indicated that street methadone was more widely used than street buprenorphine and that both drugs were largely used as self-medication for detoxification and withdrawal symptoms. Participants reported using low dosages and no injection of either medication was reported.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19874152      PMCID: PMC2771323          DOI: 10.3109/10550490903077820

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  44 in total

1.  Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London.

Authors:  J Fountain; J Strang; M Gossop; M Farrell; P Griffiths
Journal:  Addiction       Date:  2000-03       Impact factor: 6.526

2.  A randomized controlled trial of interim methadone maintenance: 10-Month follow-up.

Authors:  Robert P Schwartz; Jerome H Jaffe; David A Highfield; Jason M Callaman; Kevin E O'Grady
Journal:  Drug Alcohol Depend       Date:  2006-06-21       Impact factor: 4.492

3.  Prescription opioid use, misuse, and diversion among street drug users in New York City.

Authors:  W Rees Davis; Bruce D Johnson
Journal:  Drug Alcohol Depend       Date:  2007-10-29       Impact factor: 4.492

4.  Abuse of buprenorphine in the United States: 2003-2005.

Authors:  Meredith Y Smith; J Elise Bailey; George E Woody; Herbert D Kleber
Journal:  J Addict Dis       Date:  2007

5.  Premature discharge from methadone treatment: patient perspectives.

Authors:  Heather Schacht Reisinger; Robert P Schwartz; Shannon Gwin Mitchell; James A Peterson; Sharon M Kelly; Kevin E O'Grady; Erica A Marrari; Barry S Brown; Michael H Agar
Journal:  J Psychoactive Drugs       Date:  2009-09

6.  A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Authors:  R E Johnson; M A Chutuape; E C Strain; S L Walsh; M L Stitzer; G E Bigelow
Journal:  N Engl J Med       Date:  2000-11-02       Impact factor: 91.245

7.  Buprenorphine: "field trials" of a new drug.

Authors:  M Agar; P Bourgois; J French; O Murdoch
Journal:  Qual Health Res       Date:  2001-01

Review 8.  Methadone maintenance treatment (MMT): a review of historical and clinical issues.

Authors:  H Joseph; S Stancliff; J Langrod
Journal:  Mt Sinai J Med       Date:  2000 Oct-Nov

9.  A 33-year follow-up of narcotics addicts.

Authors:  Y I Hser; V Hoffman; C E Grella; M D Anglin
Journal:  Arch Gen Psychiatry       Date:  2001-05

10.  Risk factors for methadone outside treatment programs: implications for HIV treatment among injection drug users.

Authors:  D Vlahov; P O'Driscoll; S H Mehta; D C Ompad; R Gern; N Galai; G D Kirk
Journal:  Addiction       Date:  2007-05       Impact factor: 6.526

View more
  45 in total

1.  Patterns of buprenorphine use and risk for re-arrest among highly vulnerable opioid-involved women released from jails in rural Appalachia.

Authors:  Hilary L Surratt; Michele Staton; Carl G Leukefeld; Carrie B Oser; J Matthew Webster
Journal:  J Addict Dis       Date:  2018-12-21

2.  Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.

Authors:  Ning-Sheng Cai; César Quiroz; Jordi Bonaventura; Alessandro Bonifazi; Thomas O Cole; Julia Purks; Amy S Billing; Ebonie Massey; Michael Wagner; Eric D Wish; Xavier Guitart; William Rea; Sherry Lam; Estefanía Moreno; Verònica Casadó-Anguera; Aaron D Greenblatt; Arthur E Jacobson; Kenner C Rice; Vicent Casadó; Amy H Newman; John W Winkelman; Michael Michaelides; Eric Weintraub; Nora D Volkow; Annabelle M Belcher; Sergi Ferré
Journal:  J Clin Invest       Date:  2019-03-26       Impact factor: 14.808

3.  Buprenorphine treatment for narcotic addiction: not without risks.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2015 Mar-Apr

Review 4.  Update on the clinical use of buprenorphine: in opioid-related disorders.

Authors:  Simon Ducharme; Ronald Fraser; Kathryn Gill
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

5.  Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland.

Authors:  Becky L Genberg; Mirinda Gillespie; Charles R Schuster; Chris-Ellyn Johanson; Jacquie Astemborski; Gregory D Kirk; David Vlahov; Shruti H Mehta
Journal:  Addict Behav       Date:  2013-08-17       Impact factor: 3.913

Review 6.  The New Kid on the Block--Incorporating Buprenorphine into a Medical Toxicology Practice.

Authors:  Timothy J Wiegand
Journal:  J Med Toxicol       Date:  2016-03

7.  Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.

Authors:  Jan Gryczynski; Jerome H Jaffe; Robert P Schwartz; Kristi A Dušek; Nishan Gugsa; Cristin L Monroe; Kevin E O'Grady; Yngvild K Olsen; Shannon Gwin Mitchell
Journal:  Am J Addict       Date:  2013 May-Jun

8.  Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009.

Authors:  Robert P Schwartz; Jan Gryczynski; Kevin E O'Grady; Joshua M Sharfstein; Gregory Warren; Yngvild Olsen; Shannon G Mitchell; Jerome H Jaffe
Journal:  Am J Public Health       Date:  2013-03-14       Impact factor: 9.308

9.  Patterns of non-prescribed buprenorphine and other opioid use among individuals with opioid use disorder: A latent class analysis.

Authors:  Raminta Daniulaityte; Ramzi W Nahhas; Sydney Silverstein; Silvia Martins; Angela Zaragoza; Avery Moeller; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2019-09-22       Impact factor: 4.492

10.  Consumer attitudes about opioid addiction treatment: a focus group study in New York City.

Authors:  Nancy L Sohler; Linda Weiss; James E Egan; Carolina M López; Jamie Favaro; Robert Cordero; Chinazo O Cunningham
Journal:  J Opioid Manag       Date:  2013 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.